Mainz Biomed B.V. Profile Avatar - Palmy Investing

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product ca…

Medical - Diagnostics & Research
DE, Mainz [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Mainz Biomed B.V. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Mainz Biomed B.V. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Mainz Biomed B.V..

If you want to see a demo, head over to the financial segments of AAPL

End of MYNZ's Analysis
CIK: 1874252 CUSIP: N5436L101 ISIN: NL0015000LC2 LEI: - UEI: -
Secondary Listings
MYNZ has no secondary listings inside our databases.